Dr. Reddy's Laboratories

Dr. Reddy's Laboratories, is a multinational pharmaceutical company based in Hyderabad, Telangana, India. The company was founded by Anji Reddy, who previously worked in the mentor institute, Indian Drugs and Pharmaceuticals Limited, of Hyderabad, India. Dr. Reddy's manufactures and markets a wide range of pharmaceuticals in India and overseas. The company has over 190 medications, 60 active pharmaceutical ingredients (APIs) for drug manufacture, diagnostic kits, critical care, and biotechnology products.

Dr. Reddy's began as a supplier to Indian drug manufacturers, but it soon started exporting to other less-regulated markets that had the advantage of not having to spend time and money on a manufacturing plant that would gain approval from a drug licensing body such as the U.S. Food and Drug Administration (FDA). By the early 1990s, the expanded scale and profitability from these unregulated markets enabled the company to begin focusing on getting approval from drug regulators for their formulations and bulk drug manufacturing plants in more-developed economies. This allowed their movement into regulated markets such as the US and Europe. In 2014, Dr. Reddy Laboratories was listed among 1200 of India's most trusted brands according to the Brand Trust Report 2014, a study conducted by Trust Research Advisory, a brand analytics company.

Podcasts:

PLAYLIST TIME:

Latest News for: dr reddy’s labs

Dr Reddy's inks pact with China’s Bio-Thera

The Times of India 26 Mar 2025
Dr Reddy's Labs (DRL) on Wednesday said its subsidiary, Dr Reddy's Labs SA, entered into commercialisation and licensing agreements with China's Bio-Thera Solutions for biosimilars of two of Janssen's ...

Dr Reddy's inks South East Asia commercialisation, licence pacts with China's Bio-Thera for Stelara, Simponi biosimilars

The Times of India 26 Mar 2025
Dr Reddy’s Labs on Wednesday said its subsidiary, Dr Reddy’s Labs SA, has entered into commercialisation and licencing agreements with China’s Bio-Thera Solutions for biosimilars of two of Janssen’s ...

Indian stock markets failed to hold gains, ended flat after witnessing volatile session

Beijing News 25 Mar 2025
At NSE, the stocks of UltraTech Cement, Trent, Bajaj Finserv, Infosys, and Grasim Industries emerged as the major gainers, while the losers were IndusInd Bank, Dr Reddy's Labs, Adani Enterprises, Coal India, Adani Ports ... 25,000 crore to Rs ... (ANI). .

Top gainers & losers intraday March 17, 2025: SBI Life, Dr Reddy’s Lab lead gains, ...

Business Line 17 Mar 2025
Shares of SBI Life, Bajaj Finserv, Dr Reddy’s Laboratories, Trent and Axis Bank emerged among top gainers of Nifty 50 pack, ...

Why you should consider these healthcare stocks in a volatile market

The Times of India 12 Mar 2025
medium118921931For FY24, Neuland Labs reduced its debt from ₹121 crore to ₹82 crore ... The PE multiple is 49x.Eris Lifesciences acquired nine dermatology brands from Dr Reddy’s Labs, strengthening its position in the dermatology space.
  • 1
×